Khatri, Amit
Cheng, Ling
Camez, Anne
Ignatenko, Stanislav
Pang, Yinuo
Othman, Ahmed A.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Lack of Effect of 12-Week Treatment with Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients with Moderate to Severe Chronic Plaque Psoriasis
https://doi.org/10.1007/s40262-018-0730-x
Funding for this research was provided by:
AbbVie
Article History
First Online: 21 December 2018
Compliance with ethical standards
:
: This work was supported by Boehringer Ingelheim and AbbVie. Boehringer Ingelheim contributed to the study design and the approval of the publication. AbbVie contributed to the study design, research, and interpretation of data, and the writing, review, and approval of the publication.
: AK, LC, AC, YP, and AAO are employees and shareholders of AbbVie. SI is an employee of Charité Research Organisation GmbH, the site at which the study was performed, and has no conflicts of interest to declare.
: The study was conducted in accordance with Good Clinical Practice guidelines and the ethical principles that have their origin in the Declaration of Helsinki. The protocol was approved by the institutional review board at the study site (Ethik-Kommission des Landes Berlin, Landesamt für Gesundheit und Soziales, Berlin, Germany) and each participant provided written informed consent prior to his or her participation in the study.
: AbbVie is committed to responsible data sharing regarding the clinical trials we sponsor. This includes access to anonymized individual and trial-level data (analysis datasets), as well as other information (e.g., protocols and Clinical Study Reports), as long as the trials are not part of an ongoing or planned regulatory submission. This includes requests for clinical trial data for unlicensed products and indications. This clinical trial data can be requested by any qualified researchers who engage in rigorous, independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA). Data requests can be submitted at any time and the data will be accessible for 12 months, with possible extensions considered. For more information on the process, or to submit a request, visit the following link: ExternalRef removed.